Real Estate - REIT - Healthcare Facilities - NASDAQ - US
$ 18.18
1.34 %
$ 4.3 B
Market Cap
44.34
P/E
As of March 31, 2022, Sabra's investment portfolio included 416 real estate properties held for investment. This consists of (i) 279 Skilled Nursing/Transitional Care facilities, (ii) 59 Senior Housing communities (Senior Housing - Leased), (iii) 50 Senior Housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing - Managed), (iv) 13 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), one asset held for sale, one investment in a sales-type lease, 16 investments in loans receivable (consisting of (i) two mortgage loans, (ii) one construction loan and (iii) 13 other loans), seven preferred equity investments and one investment in an unconsolidated joint venture.[ Read More ]
The intrinsic value of one SBRA stock under the base case scenario is HIDDEN Compared to the current market price of 18.2 USD, Sabra Health Care REIT, Inc. is HIDDEN
2. FUNDAMENTAL
ANALYSIS
Price Chart SBRA
FINANCIALS
656 M
REVENUE
235 M
OPERATING INCOME
13.8 M
NET INCOME
301 M
OPERATING CASH FLOW
103 M
INVESTING CASH FLOW
-410 M
FINANCING CASH FLOW
94.6 M
REVENUE
33.7 M
OPERATING INCOME
29.8 M
NET INCOME
97.6 M
OPERATING CASH FLOW
-57 M
INVESTING CASH FLOW
-14 M
FINANCING CASH FLOW
Balance Sheet Decomposition
Sabra Health Care REIT, Inc.
| Current Assets | 543 M |
| Cash & Short-Term Investments | 46.7 M |
| Receivables | 497 M |
| Other Current Assets | 0 |
| Non-Current Assets | 4.84 B |
| Long-Term Investments | 214 M |
| PP&E | 4.63 B |
| Other Non-Current Assets | 379 K |
| Current Liabilities | 231 M |
| Accounts Payable | 73.8 M |
| Short-Term Debt | 197 M |
| Other Current Liabilities | -39 M |
| Non-Current Liabilities | 2.35 B |
| Long-Term Debt | 2.25 B |
| Other Non-Current Liabilities | 102 M |
EFFICIENCY
Earnings Waterfall
Sabra Health Care REIT, Inc.
| Revenue | 656 M |
| Cost Of Revenue | 378 M |
| Gross Profit | 278 M |
| Operating Expenses | 42.4 M |
| Operating Income | 235 M |
| Other Expenses | 221 M |
| Net Income | 13.8 M |
RATIOS
42.31%
GROSS MARGIN
35.84%
OPERATING MARGIN
2.10%
NET MARGIN
0.49%
ROE
0.26%
ROA
3.36%
ROIC
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Sabra Health Care REIT, Inc.
| Net Income | 13.8 M |
| Depreciation & Amortization | 183 M |
| Capital Expenditures | 5.24 M |
| Stock-Based Compensation | 7.92 M |
| Change in Working Capital | -2.73 M |
| Others | 85.3 M |
| Free Cash Flow | 306 M |
Wall Street Analysts Price Targets
Sabra Health Care REIT, Inc.
Wall Street analysts predict an average 1-year price target for SBRA of $17.2 , with forecasts ranging from a low of $15 to a high of $20 .
SBRA Lowest Price Target
Wall Street Target
15 USD
-17.49%
SBRA Average Price Target
Wall Street Target
17.2 USD
-5.12%
SBRA Highest Price Target
Wall Street Target
20 USD
10.01%
4. DIVIDEND ANALYSIS
1.61%
DIVIDEND YIELD
0.3 USD
DIVIDEND PER SHARE
5. COMPETITION
6. Ownership
Insider Ownership
Sabra Health Care REIT, Inc.
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
147 K USD 1
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
101 K USD 1
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
| Date | Value | Insider | Amount | Avg Price |
|---|---|---|---|---|
|
5 months ago
May 22, 2024
|
Bought 101 K USD
|
Cusack Catherine
Director |
+ 7000
|
14.43 USD |
|
6 months ago
May 14, 2024
|
Sell 147 K USD
|
FOSTER MICHAEL J
Director |
- 10000
|
14.683 USD |
|
1 year ago
Sep 01, 2023
|
Bought 24.6 K USD
|
Costa Michael Lourenco
Executive VP, CFO & Secretary |
+ 1947
|
12.63 USD |
|
2 years ago
Feb 25, 2022
|
Bought 26.5 K USD
|
Cusack Catherine
Director |
+ 2000
|
13.24 USD |
|
2 years ago
Dec 29, 2021
|
Sell 1.49 M USD
|
Andrews Harold W. Jr.
Executive VP, CFO & Secretary |
- 110000
|
13.5522 USD |
|
3 years ago
May 13, 2021
|
Bought 34.4 K USD
|
Cusack Catherine
Director |
+ 2000
|
17.19 USD |
|
3 years ago
Mar 04, 2021
|
Sell 52.2 K USD
|
FOSTER MICHAEL J
Director |
- 3000
|
17.39 USD |
|
3 years ago
Mar 04, 2021
|
Sell 52.4 K USD
|
FOSTER MICHAEL J
Director |
- 3000
|
17.48 USD |
|
3 years ago
Mar 02, 2021
|
Bought 17.3 K USD
|
Cusack Catherine
Director |
+ 1000
|
17.34 USD |
|
4 years ago
Mar 06, 2020
|
Sell 194 K USD
|
Ettl Robert A.
Director |
- 10545
|
18.3896 USD |
|
4 years ago
Mar 16, 2020
|
Bought 24.8 K USD
|
FOSTER MICHAEL J
Director |
+ 3200
|
7.75 USD |
|
4 years ago
Mar 16, 2020
|
Bought 74.6 K USD
|
FOSTER MICHAEL J
Director |
+ 9675
|
7.7136 USD |
|
5 years ago
Nov 04, 2019
|
Sell 2.72 M USD
|
MATROS RICHARD K
Chairman, CEO and President |
- 113000
|
24.0467 USD |
|
5 years ago
Aug 26, 2019
|
Sell 1.25 M USD
|
Lewis Raymond J
Director |
- 58000
|
21.4743 USD |
|
5 years ago
Aug 14, 2019
|
Sell 312 K USD
|
FOSTER MICHAEL J
Director |
- 15000
|
20.78 USD |
|
6 years ago
Mar 22, 2018
|
Sell 10.4 K USD
|
Andrews Harold W. Jr.
Executive VP, CFO & Secretary |
- 600
|
17.36 USD |
|
6 years ago
Nov 30, 2017
|
Sell 88.5 K USD
|
WALTERS MILTON J
Director |
- 4615
|
19.1795 USD |
7. News
Sabra Health Care REIT, Inc. to Attend Nareit's REITworld 2024 Annual Conference
TUSTIN, Calif.--(BUSINESS WIRE)-- #REITworld--Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that Rick Matros, the company's Chair and Chief Executive Officer, Michael Costa, the company's Chief Financial Officer, Darrin Smith, the company's Executive Vice President of Investments, and Lukas Hartwich, the company's Senior Vice President of Finance, will attend Nareit's REITworld 2024 Annual Conference on November 19-20, 2024 at the Wynn Las Vegas in Las Vegas, Nevada. About Sabra Sabra Health C.
businesswire.com
- 1 week ago
Sabra Health Care REIT, Inc. (SBRA) Q3 2024 Earnings Call Transcript
Sabra Health Care REIT, Inc. (NASDAQ:SBRA ) Q3 2024 Earnings Conference Call November 1, 2024 1:00 PM ET Company Participants Lukas Hartwich - Senior Vice President, Finance Rick Matros - Chief Executive Officer, President & Chair of the Board Talya Nevo-Hacohen - Chief Investment Officer, Treasurer & Executive Vice President Michael Costa - Chief Financial Officer Conference Call Participants Elmer Chang - Scotiabank John Kilichowski - Wells Fargo Austin Wurschmidt - KeyBanc Juan Sanabria - BMO Capital Michael Griffin - Citi Rich Anderson - Wedbush Alec Feygin - Baird Michael Stroyeck - Green Street Omotayo Okusanya - Deutsche Bank Operator Good day, everyone. My name is Adam, and I will be your conference operator today.
seekingalpha.com
- 2 weeks ago
Sabra (SBRA) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
Although the revenue and EPS for Sabra (SBRA) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
zacks.com
- 2 weeks ago
Sabra Healthcare (SBRA) Q3 FFO and Revenues Surpass Estimates
Sabra Healthcare (SBRA) came out with quarterly funds from operations (FFO) of $0.37 per share, beating the Zacks Consensus Estimate of $0.36 per share. This compares to FFO of $0.34 per share a year ago.
zacks.com
- 2 weeks ago
Moody's Upgrades Sabra Health Care REIT, Inc.'s Outlook to Positive, Affirms Credit Rating
TUSTIN, Calif.--(BUSINESS WIRE)-- #Moodys--Sabra Health Care REIT, Inc. (“Sabra”) (Nasdaq: SBRA) announced today that Moody's Ratings (“Moody's”) issued a report on October 17, 2024 affirming Sabra's Ba1 ratings and upgrading Sabra's outlook to “Positive” from “Stable”. The report credits Sabra's upgraded outlook to improving industry fundamentals for skilled nursing and senior housing, which is driving an improvement in Sabra's key credit metrics, particularly net debt to EBITDA. For additional informat.
businesswire.com
- 3 weeks ago
Sabra Health Care REIT, Inc. Announces Third Quarter 2024 Earnings Release Date and Conference Call
TUSTIN, Calif.--(BUSINESS WIRE)-- #3Q24--Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that it will issue its 2024 third quarter earnings release on October 31, 2024, after the close of trading. A conference call with a simultaneous webcast to discuss the 2024 third quarter results will be held on Friday, November 1 at 10:00 a.m. Pacific Time. The dial-in number for U.S. participants is 888-880-4448. For participants outside the U.S., the dial-in number is 646-960-0572. The conference ID.
businesswire.com
- 1 month ago
Sabra Health Care REIT, Inc. to Attend Fall Conferences
TUSTIN, Calif.--(BUSINESS WIRE)-- #asha--Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that Rick Matros, the company's Chair and Chief Executive Officer, Darrin Smith, the company's Executive Vice President of Investments, Eliza Gozar, the company's Senior Vice President of Investments, and Lauren Nisley, the company's Director of Investments, will attend the INVEST Conference on October 7-9, 2024 at the JW Marriott Dallas Arts District in Dallas, Texas. Talya Nevo-Hacohen, the company's.
businesswire.com
- 1 month ago
Sabra Health Care REIT: Turning The Corner
Sabra Healthcare REIT is showing a strong turnaround with impressive Q2 earnings, driven by increased occupancy and NOI growth, particularly in senior housing. The REIT's deleveraging efforts and strong liquidity position it well for future investments, with no debt maturing before 2026 and investment-grade ratings. Dividend growth is expected to resume in 2025, with management raising AFFO guidance, suggesting potential for share price appreciation despite lagging peers.
seekingalpha.com
- 1 month ago
10 Sweet REITs: Yield Up To 6.6%
Equity REITs, distinct from mortgage REITs, generate income from rental leases and capital appreciation, offering high yields and tax advantages by distributing 90% of taxable income. My portfolio, Rose's Income Garden (RIG), includes six of the ten highlighted REITs, chosen for their credit ratings, yields, and growth potential. Interest rates significantly impact REIT prices; current high valuations may not last, but lower rates could enhance future pricing and investment opportunities.
seekingalpha.com
- 1 month ago
Sabra Health Care REIT, Inc. to Participate in the BofA Securities 2024 Global Real Estate Conference
TUSTIN, Calif.--(BUSINESS WIRE)-- #BAML--Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that Rick Matros, the company's Chair and Chief Executive Officer, Michael Costa, the company's Chief Financial Officer, Talya Nevo-Hacohen, the company's Chief Investment Officer, Darrin Smith, the company's Executive Vice President of Investments, and Lukas Hartwich, the company's Senior Vice President of Finance, will participate in the BofA Securities 2024 Global Real Estate Conference on September.
businesswire.com
- 2 months ago
Sabra Health Care REIT, Inc. (SBRA) Q2 2024 Earnings Call Transcript
Sabra Health Care REIT, Inc. (NASDAQ:SBRA ) Q2 2024 Earnings Conference Call August 8, 2024 1:00 PM ET Company Participants Lukas Hartwich - Senior Vice President, Finance Rick Matros - Chief Executive Officer, President & Chair of the Board Talya Nevo-Hacohen - Chief Investment Officer, Treasurer & Executive Vice President Michael Costa - Chief Financial Officer Conference Call Participants Elmer Chang - Scotiabank Austin Wurschmidt - KeyBanc Capital Markets Joshua Dennerlein - Bank of America Michael Griffin - Citigroup Vikram Malhotra - Mizuho Securities John Pawlowski - Wells Fargo Rich Anderson - Wedbush Securities Michael Stroyeck - Green Street Advisors, LLC Alec Feygin - Baird Equity Research Operator Good day, everyone. My name is Christina, and I will be your conference operator today.
seekingalpha.com
- 3 months ago
Sabra (SBRA) Reports Q2 Earnings: What Key Metrics Have to Say
While the top- and bottom-line numbers for Sabra (SBRA) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
zacks.com
- 3 months ago
8. Profile Summary
Sabra Health Care REIT, Inc. SBRA
COUNTRY
US
INDUSTRY
REIT - Healthcare Facilities
MARKET CAP
$ 4.3 B
Dividend Yield
1.61%
Description
As of March 31, 2022, Sabra's investment portfolio included 416 real estate properties held for investment. This consists of (i) 279 Skilled Nursing/Transitional Care facilities, (ii) 59 Senior Housing communities (Senior Housing - Leased), (iii) 50 Senior Housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing - Managed), (iv) 13 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), one asset held for sale, one investment in a sales-type lease, 16 investments in loans receivable (consisting of (i) two mortgage loans, (ii) one construction loan and (iii) 13 other loans), seven preferred equity investments and one investment in an unconsolidated joint venture. As of March 31, 2022, Sabra's real estate properties held for investment included 41,445 beds/units, spread across the United States and Canada.
Contact
18500 Von Karman Avenue, Irvine, CA, 92612
https://www.sabrahealth.com
IPO Date
April 2, 2002
Employees
48
Officers
Mr. Michael Lourenco Costa
Executive Vice President, Chief Financial Officer & Secretary
Mr. Peter W. Nyland
Executive Vice President of Asset Management
Mr. Darrin L. Smith
Executive Vice President of Investments
Mr. Richard K. Matros
Chairman, President & Chief Executive Officer
Mr. Lukas Michael Hartwich C.F.A.
Senior Vice President of Finance
Ms. Jessica Flores
Executive Vice President, Chief Accounting Officer & Principal Accounting officer
Ms. Eliza Gozar
Senior Vice President of Investments
Ms. Talya Nevo-Hacohen
Executive Vice President, Chief Investment Officer & Treasurer